Title: 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
Journal: Bioorganic & medicinal chemistry 20131201
Title: A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.
Journal: mBio 20130101
Title: Disposition and metabolism of safinamide, a novel drug for Parkinson's disease, in healthy male volunteers.
Journal: Pharmacology 20130101
Title: The effect of safinamide, a novel drug for Parkinson's disease, on pressor response to oral tyramine: a randomized, double-blind, clinical trial.
Journal: Clinical pharmacology and therapeutics 20121001
Title: Emerging therapies for Parkinson's disease.
Journal: Current opinion in neurology 20120801
Title: Managing the patient with newly diagnosed Parkinson disease.
Journal: Cleveland Clinic journal of medicine 20120701
Title: A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients.
Journal: Movement disorders : official journal of the Movement Disorder Society 20120101
Title: Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.
Journal: Journal of medicinal chemistry 20111208
Title: Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20111201
Title: Monoamine oxidase B inhibitors for the treatment of Parkinson's disease: a review of symptomatic and potential disease-modifying effects.
Journal: CNS drugs 20111201
Title: Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological therapies.
Journal: Current topics in medicinal chemistry 20111101
Title: 3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B.
Journal: Journal of medicinal chemistry 20110922
Title: Medical management of Parkinson's disease: focus on neuroprotection.
Journal: Current neuropharmacology 20110601
Title: A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesilate, a new anti-Parkinson drug.
Journal: Journal of pharmaceutical and biomedical analysis 20110428
Title: Available and emerging treatments for Parkinson's disease: a review.
Journal: Drug design, development and therapy 20110101
Title: Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).
Journal: Journal of drug delivery 20110101
Title: Safinamide in the treatment of Parkinson's disease.
Journal: Expert opinion on pharmacotherapy 20100901
Title: The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement Disorders.
Journal: IDrugs : the investigational drugs journal 20100801
Title: Two polymorphs of safinamide, a selective and reversible inhibitor of monoamine oxidase B.
Journal: Acta crystallographica. Section C, Crystal structure communications 20100601
Title: Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities.
Journal: Journal of medicinal chemistry 20100513
Title: Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs.
Journal: Drugs of today (Barcelona, Spain : 1998) 20100401
Title: Superpose3D: a local structural comparison program that allows for user-defined structure representations.
Journal: PloS one 20100101
Title: Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.
Journal: Pharmacological reports : PR 20090101
Title: An expert opinion on safinamide in Parkinson's disease.
Journal: Expert opinion on investigational drugs 20080701
Title: Computational systems analysis of dopamine metabolism.
Journal: PloS one 20080101
Title: Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.
Journal: Pharmacotherapy 20071201
Title: Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs.
Journal: Journal of medicinal chemistry 20071115
Title: Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase.
Journal: Journal of medicinal chemistry 20071004
Title: Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome.
Journal: Current opinion in investigational drugs (London, England : 2000) 20070701
Title: Safinamide.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20070101
Title: Safinamide: from molecular targets to a new anti-Parkinson drug.
Journal: Neurology 20061010
Title: Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition.
Journal: Neurology 20061010
Title: New pharmacologic horizons in the treatment of Parkinson disease.
Journal: Neurology 20061010
Title: Bioassay of safinamide in biological fluids of humans and various animal species.
Journal: Arzneimittel-Forschung 20060101
Title: Voltage gated ion channels: targets for anticonvulsant drugs.
Journal: Current topics in medicinal chemistry 20050101
Title: Improvement of motor function in early Parkinson disease by safinamide.
Journal: Neurology 20040824
Title: Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity.
Journal: Pharmacological research 20040701
Title: Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class.
Journal: Journal of medicinal chemistry 20040325
Title: Safinamide: FCE 26743, NW 1015, PNU 151774, PNU 151774E.
Journal: Drugs in R&D 20040101
Title: Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).
Journal: Epilepsy research 20040101
Title: Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition.
Journal: Clinical neuropharmacology 20030101
Title: Novel anticonvulsant medications in development.
Journal: Expert opinion on investigational drugs 20021001
Title: Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).
Journal: Epilepsy research 20020901
Title: Safinamide (Newron Pharmaceuticals).
Journal: Current opinion in investigational drugs (London, England : 2000) 20010601
Title: Future prospects for the drug treatment of epilepsy.
Journal: CNS drugs 20010101
Title: Leonetti F, et al. Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase. J Med Chem, 2007, 50(20), 4909-4916.
Title: C Caccia, et al.Safinamide: from molecular targets to a new anti-Parkinson drug. Neurology. 2006 Oct 10;67(7 Suppl 2):S18-23.
Title: Michele Morari, et al. Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia.J Pharmacol Exp Ther. 2018 Feb;364(2):198-206.
